SONG PAUL Y. enters NKGEN BIOTECH, INC. with 170.31K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 10/10/2023ACC: 0001209191-23-052514
DirectorOfficer· Chief Executive Officer
Since Sep 2023
170.31K
Baseline shares
100% direct
170.31K
Direct ownership
1 position
477.03K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned170.31K
Total
170.31K direct170.31K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 170.31K | Direct |
| Total | 170.31K | 170.31K direct |
Derivative Holdings2
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
83.72K
Shares owned
N/A
Exercise price
6.67
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
393.31K
Shares owned
N/A
Exercise price
6.67
Expiration
—
Exercise window
—
Total
Underlying
477.03K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 6.67 | — | — | 83.72K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 6.67 | — | — | 393.31K | N/A |
| Total | 477.03K | 0.00 | ||||